Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases

被引:53
|
作者
Xu, Guozhang [1 ]
Searle, Lily Lee [1 ]
Hughes, Terry V. [1 ]
Beck, Amanda K. [1 ]
Connolly, Peter J. [1 ]
Abad, Marta C. [1 ]
Neeper, Michael P. [1 ]
Struble, Geoffrey T. [1 ]
Springer, Barry A. [1 ]
Emanuel, Stuart L. [1 ]
Gruninger, Robert H. [1 ]
Pandey, Niranjan [1 ]
Adams, Mary [1 ]
Moreno-Mazza, Sandra [1 ]
Fuentes-Pesquera, Angel R. [1 ]
Middleton, Steven A. [1 ]
Greenberger, Lee M. [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, Cranbury, NJ 08512 USA
关键词
receptor tyrosine kinase; ErbB-2; EGFR; oxime; quinazoline; bioisostere;
D O I
10.1016/j.bmcl.2008.05.024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We herein disclose a novel series of 4-aminopyrimidine-5-carbaldehyde oximes that are potent and selective inhibitors of both EGFR and ErbB-2 tyrosine kinases, with IC50 values in the nanomolar range. Structure-activity relationship (SAR) studies elucidated a critical role for the 4-amino and C-6 arylamino moieties. The X-ray co-crystal structure of EGFR with 37 was determined and validated our design rationale. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3495 / 3499
页数:5
相关论文
共 50 条
  • [21] Synthesis and biological evaluation of 4-[3-chloro-4-(3-fluorobenzyloxy) anilino]-6-(3-substituted-phenoxy)pyrimidines as dual EGFR/ErbB-2 kinase inhibitors
    Li, Siyuan
    Guo, Chunying
    Zhao, Hongli
    Tang, Yun
    Lan, Minbo
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (02) : 877 - 885
  • [22] Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors
    Li, Dong-Dong
    Qin, Ya-Juan
    Sun, Jian
    Li, Jing-Ran
    Fang, Fei
    Du, Qian-Ru
    Qian, Yong
    Gong, Hai-Bin
    Zhu, Hai-Liang
    [J]. PLOS ONE, 2013, 8 (08):
  • [23] Synthesis of 2-amino-4-substituted-6-arylmethyl pyrrolo[2,3-d] pyrimidines as inhibitors of receptor tyrosine kinases
    Gangjee, Aleem
    Raghavan, Sudhir
    Ihnat, Michael
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [24] Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors
    Fischer, Tim
    Krueger, Thomas
    Najjar, Abdulkarim
    Totzke, Frank
    Schaechtele, Christoph
    Sippl, Wolfgang
    Ritter, Christoph
    Hilgeroth, Andreas
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (12) : 2708 - 2712
  • [25] MEDI 446-Pyrrolotriazine dual EGFR/HER2 protein tyrosine kinase inhibitors with solubilizing groups at C-5
    Kastrati, Irida
    Qin, Zhihui
    Petukhov, Pavel A.
    Bolton, Judy L.
    Thatcher, Gregory R. J.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 922 - 922
  • [26] Pyrrolotriazine-5-carboxylate ester inhibitors of EGFR and HER2 protein tyrosine kinases and a novel one-pot synthesis of C-4 subsitituted pyrrole-2,3-dicarboxylate diesters
    Mastalerz, Harold
    Gavai, Ashvinikumar V.
    Fink, Brian
    Struzynski, Charles
    Tarrant, James
    Vite, Gregory D.
    Wong, Tai W.
    Zhang, Guifen
    Vyas, Dolatrai M.
    [J]. CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 2006, 84 (04): : 528 - 533
  • [27] [4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors
    Garofalo, Antonio
    Goossens, Laurence
    Lemoine, Amelie
    Ravez, Severine
    Six, Perdue
    Howsam, Michael
    Farce, Amaury
    Depreux, Patrick
    [J]. MEDCHEMCOMM, 2011, 2 (01) : 65 - 72
  • [28] Discovery and Evaluation of Novel Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic Acid Scaffold
    He, Yantao
    Xu, Jie
    Yu, Zhi-Hong
    Gunawan, Andrea M.
    Wu, Li
    Wang, Lina
    Zhang, Zhong-Yin
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (03) : 832 - 842
  • [29] Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: Design, synthesis and biological evaluations
    Zhang, Yong
    Zhang, Kai
    Zhao, Meng
    Zhang, Lixia
    Qin, Mingze
    Guo, Shuchun
    Zhao, Yanfang
    Gong, Ping
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (15) : 4591 - 4607
  • [30] Novel 2-amino-4-anilino-6-methyl-5-substituted pyrrolo[2,3-D]pyrimidines as potential receptor tyrosine kinase inhibitors.
    Gangjee, A
    Jain, H
    Ihnat, M
    Kamat, S
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U13 - U13